JA PCM

The main objective of JA PCM (Joint Action Personalised Cancer Medicine) is to improve access to personalised cancer care in European countries and to increase knowledge about precision oncology. To this end, interventions will be developed involving all relevant stakeholders: the healthy population, the cancer patient and their loved ones, and the cancer survivors. JA PCM focuses on three key themes:

• personalised prevention and early detection;
• personalised cancer care;
• personalised surveillance and tertiary prevention.

The JA PCM will result in a roadmap for personalised cancer care in Europe and a sustainability plan that is aligned with other initiatives and the European Action Plan against Cancer.

Duration of the project: 2025-2029 (project is in the application phase).

Project budget: €25 million

Partners in Estonia: ESTCAN, University of Tartu Hospital, North Estonia Medical Centre, East Tallinn Central Hospital, Health Insurance Fund and Ministry of Social Affairs as observers.

ESTCAN contact person: Anni Lepland, anni.lepland@ut.ee.